
Meridian Bioscience VIVO
Quartalsbericht 2022-Q4
hinzugefügt 09.02.2023
Meridian Bioscience DPO 2011-2026 | VIVO
DPO Jährlich Meridian Bioscience
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 37.2 | 37 | 36 | 31.9 | 27.5 | 37.1 | 40.8 | 33.3 | 25.3 | 30.2 | 33.2 | 33.5 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 40.8 | 25.3 | 33.6 |
DPO Vierteljährlich Meridian Bioscience
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 57.8 | - | - | 34.1 | 32.6 | - | 42.9 | 44.9 | 39.7 | 15.3 | 37.9 | 28.9 | 35 | 10.8 | 32.7 | 30.8 | 28.6 | 9.22 | 28.9 | 33.8 | 36.5 | 12.3 | 37.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 57.8 | 9.22 | 31.5 |
DPO anderer Aktien in der Diagnostik & Forschung
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
120 | - | -6.23 % | $ 30.6 M | ||
|
Enzo Biochem
ENZ
|
52.3 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
49.2 | - | - | $ 19.8 B | ||
|
Akumin
AKU
|
21.3 | - | -17.87 % | $ 25.9 M | ||
|
Sotera Health Company
SHC
|
46.9 | $ 13.28 | -1.96 % | $ 3.77 B | ||
|
Agilent Technologies
A
|
50.1 | $ 110.88 | -2.29 % | $ 33.7 B | ||
|
Heska Corporation
HSKA
|
39.7 | - | - | $ 1.31 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
45.8 | - | - | $ 562 M | ||
|
BioNano Genomics
BNGO
|
149 | $ 1.15 | - | $ 6.26 M | ||
|
Burning Rock Biotech Limited
BNR
|
125 | $ 16.57 | -10.43 % | $ 178 M | ||
|
DermTech
DMTK
|
47.4 | - | -11.32 % | $ 2.94 M | ||
|
Aspira Women's Health
AWH
|
112 | - | -6.19 % | $ 10.5 M | ||
|
DexCom
DXCM
|
67.7 | $ 62.48 | -5.47 % | $ 24.4 B | ||
|
Accelerate Diagnostics
AXDX
|
125 | - | -61.36 % | $ 2.46 M | ||
|
Co-Diagnostics
CODX
|
106 | $ 4.4 | 101.83 % | $ 129 M | ||
|
Global Cord Blood Corporation
CO
|
17.7 | - | - | $ 399 M | ||
|
Fulgent Genetics
FLGT
|
34.9 | $ 15.62 | -4.64 % | $ 472 M | ||
|
Fluidigm Corporation
FLDM
|
61.4 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
780 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
43.5 | - | 0.12 % | $ 80.1 M | ||
|
Guardant Health
GH
|
48.6 | $ 85.04 | -3.47 % | $ 10.7 B | ||
|
HTG Molecular Diagnostics
HTGM
|
112 | - | -20.0 % | $ 1.06 M | ||
|
Castle Biosciences
CSTL
|
52 | $ 24.15 | -2.23 % | $ 671 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
8.98 | - | - | $ 10.7 B | ||
|
Charles River Laboratories International
CRL
|
24.5 | $ 158.32 | -4.12 % | $ 7.85 B | ||
|
Quest Diagnostics Incorporated
DGX
|
14.7 | $ 196.15 | -1.01 % | $ 21.8 B | ||
|
Organovo Holdings
ONVO
|
82.9 K | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
95 | - | -16.95 % | $ 1.54 M | ||
|
ICON Public Limited Company
ICLR
|
6.52 | $ 101.83 | -1.21 % | $ 8.4 B | ||
|
DarioHealth Corp.
DRIO
|
112 | $ 8.45 | - | $ 33.7 M | ||
|
Illumina
ILMN
|
56.3 | $ 117.51 | -5.54 % | $ 18.7 B | ||
|
Biocept
BIOC
|
56.3 | - | -13.05 % | $ 7.29 M | ||
|
PerkinElmer
PKI
|
57.9 | - | -0.91 % | $ 14.7 B | ||
|
Invitae Corporation
NVTA
|
69 | - | - | $ 21.2 M | ||
|
Interpace Biosciences
IDXG
|
34.4 | $ 1.68 | -2.89 % | $ 7.37 M | ||
|
IQVIA Holdings
IQV
|
126 | $ 164.58 | -2.85 % | $ 28.3 B | ||
|
Motus GI Holdings
MOTS
|
1.72 | - | -34.28 % | $ 263 K | ||
|
QIAGEN N.V.
QGEN
|
50 | - | - | $ 10.6 B | ||
|
Neogen Corporation
NEOG
|
62.7 | $ 8.84 | -3.39 % | $ 1.92 B | ||
|
Chembio Diagnostics
CEMI
|
52.5 | - | 0.22 % | $ 16.8 M | ||
|
Personalis
PSNL
|
67.3 | $ 6.4 | -12.64 % | $ 379 M | ||
|
Laboratory Corporation of America Holdings
LH
|
31.5 | $ 266.29 | -0.78 % | $ 22.2 B | ||
|
Senseonics Holdings
SENS
|
68 | $ 6.54 | -0.3 % | $ 273 M | ||
|
Psychemedics Corporation
PMD
|
16 | - | -1.84 % | $ 15.3 M | ||
|
Precipio
PRPO
|
53 | $ 26.03 | -1.92 % | $ 33.8 M | ||
|
CareDx, Inc
CDNA
|
44.2 | $ 16.83 | -3.66 % | $ 897 M | ||
|
Quotient Limited
QTNT
|
86.2 | - | -11.32 % | $ 1.1 M | ||
|
Syneos Health
SYNH
|
10.1 | - | - | $ 4.46 B |